ロード中...

Attacking malignant cells that survive therapy: Exploiting immunogenic modulation

We have recently defined “immunogenic modulation,” a mechanism whereby malignant cells that survive anticancer therapy, due to sublethal delivery or development of treatment resistance, become nonetheless more sensitive to killing by cytotoxic T lymphocytes. This mechanism can be exploited to identi...

詳細記述

保存先:
書誌詳細
主要な著者: Hodge, James W, Kwilas, Anna, Ardiani, Andressa, Gameiro, Sofia R
フォーマット: Artigo
言語:Inglês
出版事項: Landes Bioscience 2013
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902115/
https://ncbi.nlm.nih.gov/pubmed/24498561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26937
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!